INSY - INSYS Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 522.1M
Enterprise Value 3-48.18M
Trailing P/E N/A
Forward P/E 1-0.58
PEG Ratio (5 yr expected) 1-0.01
Price/Sales (ttm)0.34
Price/Book (mrq)N/A
Enterprise Value/Revenue 3-0.73
Enterprise Value/EBITDA 60.37

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-208.49%

Management Effectiveness

Return on Assets (ttm)-40.20%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)65.8M
Revenue Per Share (ttm)0.89
Quarterly Revenue Growth (yoy)-68.10%
Gross Profit (ttm)71.28M
EBITDA -129.59M
Net Income Avi to Common (ttm)-227.98M
Diluted EPS (ttm)-3.0710
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)83.89M
Total Cash Per Share (mrq)1.12
Total Debt (mrq)14M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.54
Book Value Per Share (mrq)-2.20

Cash Flow Statement

Operating Cash Flow (ttm)-55.24M
Levered Free Cash Flow (ttm)-45.55M

Trading Information

Stock Price History

Beta (3Y Monthly) 4.03
52-Week Change 3-96.25%
S&P500 52-Week Change 35.62%
52 Week High 311.6500
52 Week Low 30.1400
50-Day Moving Average 31.6449
200-Day Moving Average 33.8861

Share Statistics

Avg Vol (3 month) 33.75M
Avg Vol (10 day) 323.38M
Shares Outstanding 575.92M
Float 27.96M
% Held by Insiders 163.69%
% Held by Institutions 124.38%
Shares Short (May 31, 2019) 410.39M
Short Ratio (May 31, 2019) 45.7
Short % of Float (May 31, 2019) 438.02%
Short % of Shares Outstanding (May 31, 2019) 413.93%
Shares Short (prior month Apr 30, 2019) 411.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 8, 2015